Opioid receptor modulator dosage formulations | Patent Number 11160792

US 11160792 B2
Application Number17211274
Publication NumberUS 20210205269 A1
Pendency7 months, 13 days
Filled DateMar 24, 2021
Priority DateMar 14, 2013
Publication DateJul 8, 2021
Expiration DateMar 13, 2033
Inventor/ApplicantsPhilip Ema H. Heyns
Jens Jozef Ceulemans
Tim Costello
Philip Erna H. Heyns
Eugeen Maria Jozef Jans
ExaminesSTEVENS, MARK V
Art Unit1613
Technology Center1600
Assignments
Allergan Holdings France S.a.s.
Current
Allergan Holdings France S.a.s.Abbvie Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.